RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 45-55
  • Saving lives one step at a time

    Saving lives one step at a time
    For years people around the country have been climbing mountains for CureDuchenne. As they raise money and awareness, they also get younger. Most recently, 8-year-old Tyler Armstrong climbed Mt. Kilimanjaro and helped raise about $40,000 for the Newport...
  • AIDS deaths worldwide drop as access to drugs improves

    AIDS deaths worldwide drop as access to drugs improves
    LOS ANGELES/GENEVA (Reuters) - Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday. The United Nations...
  • Genital warts tied to range of cancers

    Genital warts tied to range of cancers
    NEW YORK (Reuters Health) - People who've ever had genital warts may have a somewhat higher risk of several types of cancer — possibly including common skin cancers, a new study suggests. The findings, reported in the Journal of Infectious...
  • Dangerous pharmaceuticals marketed as supplements

    Dangerous pharmaceuticals marketed as supplements
    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle. Such a person would have "maybe some stomach problem, but not die," he told...
  • Human Genome Sciences rebuffs $2.6 billion offer from GlaxoSmithKline

    Shares of Human Genome Sciences doubled in Thursday morning trading on news that a major British biopharmaceutical company offered to buy it for $2.6 billion, which the Rockville company rejected as too low. Human Genome, which uses the human DNA...
  • Women on the Pill have less menstrual pain

    Women on the Pill have less menstrual pain
    NEW YORK (Reuters Health) - Young women on birth control pills tend to have less painful menstrual periods than those not on the contraceptives, a new study finds. Swedish researchers found that of 2,100 women followed from age 19 to 24, those on the...
  • Antidepressants and pregnancy

    Antidepressants and pregnancy
    Upon learning they are pregnant, most women dutifully nix the alcohol, sushi and caffeine. But what about antidepressants? Headlines about the potential risks of antidepressants on a developing fetus, including miscarriage, premature birth and newborn...
  • EU advises all girls need cervical cancer vaccines

    EU advises all girls need cervical cancer vaccines
    LONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...
  • Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...
  • Group backs HPV shot recommendation for boys

    Group backs HPV shot recommendation for boys
    NEW YORK (Reuters Health) - Boys 11 years and up should get Merck & Co's Gardasil vaccine to protect them against HPV infections, which can cause genital warts as well as oral, penile and anal cancers, the nation's largest group of pediatricians said...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...